Accuray Inc. Announces Executive and Director Changes

Ticker: ARAY · Form: 8-K · Filed: Aug 22, 2025 · CIK: 1138723

Sentiment: neutral

Topics: management-change, governance, personnel

TL;DR

Accuray's board and exec team got a refresh on Aug 19th.

AI Summary

Accuray Incorporated announced on August 19, 2025, changes in its executive and director roles. The company elected new directors and appointed new officers, alongside adjustments to its compensatory arrangements for certain executives. These changes are effective as of August 19, 2025.

Why It Matters

Changes in key leadership and director positions can signal shifts in company strategy, governance, or operational focus, potentially impacting investor confidence and future performance.

Risk Assessment

Risk Level: low — This filing reports routine corporate governance changes and does not indicate immediate financial distress or significant operational shifts.

Key Players & Entities

FAQ

What specific roles were affected by the changes announced on August 19, 2025?

The filing indicates changes related to the 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers' and 'Compensatory Arrangements of Certain Officers', suggesting shifts in directorial and executive positions and their compensation.

Are the changes in directors and officers effective immediately?

The filing states 'Date of Report (Date of earliest event reported): August 19, 2025' and 'DATE AS OF CHANGE: 20250822', indicating the changes are effective around August 19-22, 2025.

What is the primary business of Accuray Incorporated?

Accuray Incorporated is in the 'SURGICAL & MEDICAL INSTRUMENTS & APPARATUS' industry, SIC code 3841.

Where are Accuray Incorporated's principal executive offices located?

The principal executive offices are located at 1240 Deming Way, Madison, Wisconsin, 53717-1954.

What is the SEC file number for Accuray Incorporated?

The SEC file number for Accuray Incorporated is 001-33301.

Filing Stats: 592 words · 2 min read · ~2 pages · Grade level 12.1 · Accepted 2025-08-22 16:01:57

Key Financial Figures

Filing Documents

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. ACCURAY INCORPORATED Date August 22, 2025 By: /s/ Jesse Chew Jesse Chew Senior Vice President, Chief Legal Officer and Corporate Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing